Nonviral delivery platform for therapeutic RNAi: pegylated siRNA/cationic liposome complexes for targeting of the proto-oncogene bcl-2

By Hööbel Sabrina   Aigner Achim  

Future Oncology, Vol. 5, Iss. 1, 2009-02 ,pp. : 13-17

Future Medicine

Access to resources Recommend Favorite

Downregulation of survivin expression exerts antitumoral effects on mouse breast cancer cells in vitro and in vivo

By          

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 159-167

Spandidos Publications

Access to resources Recommend Favorite

Combined use of adenoviral vector Ad5/F35-mediated APE1 siRNA enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in hepatoma cells in vitro and in vivo

By              

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2197-2204

Spandidos Publications

Access to resources Recommend Favorite

Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro

By                  

International Journal of Oncology, Vol. 46, Iss. 5, 2015-01 ,pp. : 2138-2142

Spandidos Publications

Access to resources Recommend Favorite

Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo

By Zhang Yingchao   Wang Yu   Gao Wenxin   Zhang Ruhui   Han Xichun   Jia Mingku   Guan Wenzeng  

Breast Cancer Research and Treatment, Vol. 103, Iss. 1, 2007-05 ,pp. : 129-129

Springer Publishing Company

Access to resources Recommend Favorite